Gabriel Ling serves as Executive at Oncology Institute, Inc., where they oversee executive responsibilities. Since joining the company, Gabriel Ling has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 20, 2025 involved receiving (via award) 46,296 shares valued at $0.
Gabriel Ling currently holds 296,502 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gabriel Ling has been a net neutral trader of TOI stock. They have purchased $0 and sold $0 worth of shares.
Gabriel Ling's most recent insider trade was on Nov 20, 2025, when they sold 46,296 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 18, 2025 | TOI | $0 | Other | 141,149 | $N/A | Discretionary |
| Dec 26, 2023 | TOI | $0 | Award | 40,000 | $N/A | Discretionary |
| Nov 17, 2022 | TOI | $0 | Award | 29,057 | $N/A | Discretionary |